Survival rates for oral cancer depend heavily on the stage at diagnosis. At CION, the 1-year survival rate is 80.0%, compared with a national average of 71.6%.* The earlier a warning sign is checked, the wider the range of treatment options.
A survival rate is the percentage of people still living a set time after diagnosis — most often measured at one or five years. It is an average across many patients, not a prediction for any one person. Your own outlook depends on the stage, the size and site of the cancer, your general health, and your treatment plan.
The most important thing to understand is this: stage at diagnosis drives the number more than anything else. Oral cancer found early — while it is small and has not spread — has a far wider range of treatment options than cancer found late.
Because the early signs of oral cancer are often painless, many cases are found late. A persistent ulcer, patch, or lump that lasts more than three weeks deserves a quick check — early review keeps every option open.
At CION, the 1-year survival rate for oral cancer is 80.0%, compared with a national average of 71.6%.* Every patient is reviewed by a tumour board — medical, surgical, and radiation oncologists deciding together. *1-year survival. Source: ICMR–NCRP.
Cancer caught early, while it is small and localised, is far more treatable than cancer that has already spread to lymph nodes or distant sites.
Where the cancer starts — lip, tongue, cheek, gum, or floor of the mouth — and how large it is both influence the treatment options and the outlook.
Whether the cancer has reached the lymph nodes in the neck is a key part of staging and one of the strongest signals for planning treatment.
Continuing tobacco or areca (betel) nut use during and after treatment can lower outcomes. Stopping is one of the most powerful steps you can take.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
The number that matters most is the one you can change — how early you act. A quick check today gives you answers and peace of mind.
These are 1-year survival rates — the share of patients still living one year after diagnosis. CION figures reflect tumour-board-led, multi-disciplinary care across our centres. They are averages, not a prediction for any one person.
| Cancer | CION | National average | Difference |
|---|---|---|---|
| Oral | 80.0% | 71.6% | +8.4% |
| Breast | 96.9% | 85.4% | +11.5% |
| Cervical | 83.3% | 67.3% | +16.0% |
| Ovary | 81.0% | 73.7% | +7.3% |
*1-year survival. Source: ICMR–NCRP. Figures are averages across patients and do not predict the outcome for any individual.
Medical, surgical, and radiation oncologists review your case together — decisions are made by a team, not a single doctor, so the plan reflects every option.
Because stage drives the outlook, we get accurate staging right before treatment begins — a careful examination and only the tests that are genuinely needed.
Surgery, radiation, or a combination — matched to your stage and general health, and explained in plain language with transparent costs.
Nutrition, rehabilitation, and regular follow-up support recovery and help catch any recurrence early. We walk this journey with you.
In India, tobacco and areca (betel) nut are the leading causes of oral cancer, and many cases are detected late because the early ulcer or patch is painless. Catching a warning sign early is the single biggest factor you can influence. (Source: ICMR–NCRP cancer incidence reports.)
Hear from people who faced an oral cancer diagnosis and found clear, compassionate, team-led care at CION.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Survival depends heavily on the stage at diagnosis. At CION Cancer Clinics, the 1-year survival rate for oral cancer is 80.0%, compared with a national average of 71.6%. Oral cancer found early, while it is small and has not spread, has a much wider range of treatment options and better outcomes than cancer found late. Because the early signs are often painless, regular mouth checks matter.
Yes. Stage is the single biggest factor. Cancer caught at an early, localised stage is far more treatable than cancer that has already spread to lymph nodes or distant sites. This is why a mouth ulcer or patch that lasts more than three weeks should be checked without delay — catching it early keeps every option open.
A 1-year survival rate is the percentage of people who are still living one year after diagnosis. It is one way of measuring outcomes, but it is an average across many patients. Your own outlook depends on the stage, the location of the cancer, your general health, and the treatment plan. A doctor can explain what the numbers mean for your specific situation.
Every patient at CION is reviewed by a tumour board — medical, surgical, and radiation oncologists deciding together rather than one doctor alone. Care is multi-disciplinary and evidence-based, with a 45-minute consultation, no unnecessary tests, and transparent costs. Decisions are made for healing, not billing. The CION 1-year survival rate for oral cancer is 80.0% versus 71.6% nationally.
The main factors are the stage at diagnosis, the size and site of the tumour, whether it has spread to lymph nodes, and your overall health. Continuing tobacco or areca-nut use during and after treatment can lower outcomes. Early detection and a complete, team-led treatment plan have the biggest positive effect on survival.
Many oral cancers, especially those found early, can be treated successfully with surgery, radiation, or a combination of treatments. We avoid promising guaranteed outcomes — every case is different. What we can promise is a tumour-board plan tailored to you, clear costs, and a team that walks the journey with you. The earlier the cancer is found, the wider the range of options.
Get any persistent mouth ulcer, patch, or lump checked early — do not wait for it to become painful. Complete the full treatment plan your team recommends, attend follow-up visits, and stop tobacco and areca-nut use. At CION, a free first consultation and a team-led plan help you take the right next step with confidence.
CION Cancer Clinics offers a free, doctor-led mouth examination across its centres in Hyderabad and beyond. The first consultation is free, confidential, and 45 minutes long, with clear costs and no unnecessary tests. You can book a consultation online or call 1800 202 8726.